Patterson Companies Competitors and Similar CompaniesClear all

Takeda's competitors and similar companies include Henry Schein and Vivesto.

	Takeda Takeda Pharmaceutical (武田薬品工業株式会社) is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products.	Henry Schein Henry Schein is a provider of healthcare products and services to dental and medical practitioners.	Vivesto Vivesto (formerly known as Oasmia Pharmaceutical) develops, manufactures, markets, and sells drugs in the field of human and veterinary oncology.
Founding Date	Founding Date 1781	Founding Date 1932	Founding Date 1990
Type	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare dental distribution enterprise software healthtech medical devices medtech pharma	Tags Healthcare distribution drug development oncology pharma therapy veterinary
Locations	Locations Tokyo, JP HQ Buenos Aires, AR The Rocks, AU Linz, AT Wien, AT Wien, AT Lessines, BE see more	Locations Melville, US HQ Sydney, AU Vienna, AT Vilvoorde, BE Niagara On The Lake, CA Prague, CZ Paris, FR see more	Locations Uppsala, SE HQ Solna, SE
Employees	Employees 47,4554% decrease	Employees 25,000	Employees 4
Valuation ($)	Valuation ($) 43.7 b	Valuation ($) 8.9 b	Valuation ($) 13.6 m
Financial
Revenue (est.)	Revenue (est.) ¥4.6t (FY, 2025)	Revenue (est.) $13.2b (FY, 2025)	Revenue (est.) N/A
Cost of goods	Cost of goods ¥818.8b (FY, 2025)	Cost of goods $9.1b (FY, 2025)	Cost of goods N/A
Gross profit	Gross profit ¥3.8t (FY, 2025)	Gross profit $4.1b (FY, 2025)	Gross profit N/A
Net income	Net income ¥108.1b (FY, 2025)	Net income $419m (FY, 2025)	Net income (kr34.1m) (FY, 2025)
Funding
Total funding raised	Total funding raised $ 57.8m	Total funding raised $ 250m	Total funding raised $ 19.3m